MAC logo

MAC

Macerich Company (The)

$18.63
-$0.09(-0.48%)
70
Overall
80
Value
90
Tech
42
Quality
Market Cap
$4.55B
Volume
1.33M
52W Range
$12.48 - $21.00
Target Price
$19.93

Company Overview

Mkt Cap$4.55BPrice$18.63
Volume1.33MChange-0.48%
P/E Ratio-23.5Open$18.67
Revenue$850.5MPrev Close$18.72
Net Income$-194.1M52W Range$12.48 - $21.00
Div Yield0.68%Target$19.93
Overall70Value80
Quality42Technical90

No chart data available

About Macerich Company (The)

Macerich is a fully integrated, self-managed, and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich's portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, D.C. corridor. Developing and managing properties that serve as community cornerstones, Macerich currently owns 45 million square feet of real estate consisting primarily of interests in 41 retail centers. Macerich is firmly dedicated to advancing environmental goals, social good and sound corporate governance. A recognized leader in sustainability, Macerich has achieved a #1 Global Real Estate Sustainability Benchmark (GRESB) ranking for the North American retail sector for ten consecutive years (2015-2024).

Sector: Real Estate
Industry: REIT - Retail

Latest News

Cantor Fitzgerald Sticks to Its Buy Rating for Diamedica Therapeutics (DMAC)

Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Diamedica Therapeutics yesterday and set a price target of $25.00. The company...

TipRanks Auto-Generated Intelligence Newsdesk12 days ago

Marechale Capital Posts Wider Interim Loss but Touts Stronger Pipeline and Strategic Investors

TipRanks UK Auto-Generated Newsdesk15 days ago

Berenberg Bank Keeps Their Buy Rating on Macfarlane (MACF)

TipRanks Auto-Generated Intelligence Newsdesk21 days ago

Analysts Conflicted on These Real Estate Names: Curbline Properties Corp. (CURB) and Macerich (MAC)

Brian Andersona month ago

DiaMedica Therapeutics Raises Capital via Share Offering

TipRanks Auto-Generated Newsdeska month ago
ABCD
1SymbolPriceChangeVol
2MAC$18.63-0.5%1.33M
3
4
5
6

Get Macerich Company (The) Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.